Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Nick Glover | M | 55 |
YM BioSciences, Inc.
 YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 10 anni |
| Mary Christina Thomson | F | 53 | 2 anni | |
| Nicole Onetto | M | 71 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 5 anni |
| Robert E. Pelzer | M | 70 | 7 anni | |
| Justin T. Huang | M | - | - | |
| Stephen Dilly | M | 64 | 2 anni | |
| Andrew Sinclair | M | 52 | 3 anni | |
| Georgia Erbez | F | 57 | 1 anni | |
| Christy Oliger | F | 54 | 1 anni | |
| Barbara Klencke | M | 66 | 7 anni | |
| Philip Frost | M | 84 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 5 anni |
| Tryon Williams | M | 84 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 17 anni |
| Daniel J. Estes | M | 43 | 2 anni | |
| Gregg Smith | M | - |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 7 anni |
| Alvin Vitangcol | M | 49 | 3 anni | |
| Kapil Dhingra | M | 64 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 1 anni |
| Jeffrey Cooper | M | 68 | 6 anni | |
| Andrew Allen | M | 57 | 5 anni | |
| Wendi V. Rodrigueza | M | 58 | 10 anni | |
| Emma McCann | F | - | 8 anni | |
| Tran Nguyen | M | 50 | 3 anni | |
| Donald Parfet | M | 71 | 4 anni | |
| Albert Cha | M | 51 | 2 anni | |
| James Topper | M | 62 | 3 anni | |
| Peter Thompson | M | 64 | 1 anni | |
| Craig Collard | M | 58 | 2 anni | |
| François Thomas | M | 66 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 5 anni |
| Gaurav Aggarwal | M | 51 | 3 anni | |
| Mona Ashiya | M | 55 | 3 anni | |
| Catherine Mackey | M | 68 |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 2 anni |
| Kevin Thomas Ryan | M | - | - | |
| Diane Gardiner | F | - | - | |
| Josh Richardson | M | 42 | 3 anni | |
| Christian Hassig | M | 52 | - | |
| Amy Barrier Altshul | F | - | - | |
| Kevin Norrett | M | 51 | 2 anni | |
| Simon Eastman | M | - | - | |
| Lauren Rose Musto | F | - | 1 anni | |
| Keith E. Anderson | M | 55 | 7 anni | |
| Sukhi Jagpal | M | 50 | 7 anni | |
| Wendy Chapman | F | 58 | 8 anni | |
| Denis G. Bosc | M | - |
YM BioSciences, Inc.
YM BioSciences, Inc. Pharmaceuticals: MajorHealth Technology YM BioSciences, Inc. operates as a drug development company, which manufactures advancing hematology and cancer-related products. It is currently advancing in late-stage products, which include CYT387, an oral small molecule inhibitor of the kinase enzymes JAK1 and JAK2; and Nimotuzumab, an EGFR targeting humanized monoclonal antibody. The company was founded in 1994 and is headquartered in Mississauga, Canada. | 2 anni |
| Chandra D. Lovejoy | F | 52 | 3 anni | |
| Mark Kowalski | M | 69 | 5 anni | |
| William D. Turner | M | 58 | 2 anni | |
| Angie You | M | 51 | 4 anni | |
| Richard A. Messmann | M | 67 | 4 anni | |
| Alexandra Marie Nieves Gonzalez | F | - | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Stati Uniti | 42 | 87.50% |
| Canada | 9 | 18.75% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- James Smith
- Contatti personali
